🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Taiwan Post-Stroke Disability Study

Recruitingn/aAges 18 Years - anyAllNational Taiwan University Hospital
NCT06772194 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Stroke remains a major health issue in Taiwan, being the fourth leading cause of death and the top cause of disability. While past research has focused on functional outcomes at three months post-stroke, stroke can cause a range of disabilities in areas such as motor function, swallowing, cognition, depression, and epilepsy. This study will investigate these disabilities by enrolling 2,000 acute stroke patients (both ischemic and hemorrhagic) from 10 medical centers across Taiwan. Data will be collected at three key points: at enrollment, three months, and twelve months post-stroke, using surveys, assessments, imaging, and blood samples. The aim is to examine the prevalence, risk factors, and long-term changes of post-stroke disabilities, ultimately seeking ways to reduce the health burden of stroke in Taiwan.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Ischemic stroke confirmed by MRI, or hemorrhagic stroke diagnosed by CT or MRI. 2. Age ≥ 18 years. 3. Pre-stroke modified Rankin Scale (mRS) score of 0, 1, or 2. 4. Post-stroke mRS score of 0, 1, 2, 3, or 4 at enrollment. 5. Able to undergo cognitive function screening and other scale assessments within 30 days post-stroke. Exclusion Criteria: 1. Transient ischemic stroke and subarachnoid hemorrhage. 2. Clear and severe psychiatric or emotional disorders before the stroke, including schizophrenia, major depressive disorder, and bipolar disorder. 3. History of clinical stroke within three months prior to enrollment. 4. Unable to communicate or cooperate for assessments due to severe aphasia. 5. Severe dementia prior to the stroke. 6. Pre-stroke modified Rankin Scale (mRS) score ≥ 3. 7. Post-stroke mRS score of 5 at enrollment. 8. History of cancer with an expected life expectancy of less than one year. 9. Expected life expectancy of less than one year due to other medical conditions. 10. Anticipated inability to complete a one-year follow-up. 11. Other situations deemed unsuitable for enrollment by the clinical investigator.
💊

What it tests

  • Not listed
📍

Where

1 site
National Taiwan University Hospital, Taipei,
Taipei, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy